News
Lars Fruergaard Jørgensen. How a love story launched the company behind Ozempic, Wegovy Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders ...
When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge Lund, he was expecting an ordinary catchup. advertisement.
Bagsværd, Denmark, 16 May 2025 – Novo Nordisk today announced changes to its executive leadership and Board of Directors. As per mutual agreement with the Novo Nordisk Board, Lars Fruergaard ...
Lars Rebien Sørensen has pharmaceutical industry expertise from his 16-year tenure as CEO. In the pre-market trading, 5.37% lesser at $62.60 on the New York Stock Exchange.
Lars Rebien Sørensen adds: "I have the greatest respect for the achievements of Lars Fruergaard Jørgensen and Novo Nordisk A/S in recent years. The company has been through an incredible journey.
LONDON — Lars Fruergaard Jørgensen, who led Novo Nordisk as it rode the boom of its obesity and diabetes medications to become one of the biggest players in pharma, only to see that success ...
Reuters. FILE PHOTO: CEO of Novo Nordisk Lars Fruergaard Jorgensen is seen during the 6th edition of the "Choose France" Summit at the Chateau de Versailles, outside Paris on May 15, 2023.
The company behind the weight loss sensation that transformed bodies and bank accounts across America just showed its own CEO the door. Novo Nordisk announced Friday that Lars Fruergaard Jorgensen ...
Novo Nordisk CEO Lars Fruergaard Jorgensen has called attention to the complexities of the U.S. healthcare system while justifying the company’s drug pricing – prices that Senator Bernie ...
Lars Fruergaard Jørgensen joined Novo Nordisk in 1991 and was appointed chief executive officer in January 2017. During his time at the helm, the company has grown tremendously, fortified its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results